MARIA CENZON: Open Payments
NPI 1104995778 · VIRGINIA BEACH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,497 in 33 payments from 11 companies in 2025. Trend: 2023 $2,817 · 2024 $3,297 · 2025 $2,497
Food & beverage: $2,398Education: $99
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 8 | $536 |
| E.R. Squibb & Sons, L.L.C. | 7 | $416 |
| Janssen Pharmaceuticals, Inc | 4 | $335 |
| ABBVIE INC. | 3 | $256 |
| Alkermes, Inc. | 3 | $249 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $228 |
| Axsome Therapeutics, Inc. | 2 | $222 |
| Vanda Pharmaceuticals Inc. | 1 | $123 |
| Otsuka America Pharmaceutical, Inc. | 1 | $101 |
| Neurocrine BioSciences, Inc. | 1 | $19 |
Products named: COBENFY, INVEGA SUSTENNA, UZEDY, VRAYLAR, CAPLYTA, Auvelity, AUSTEDO XR, ARISTADA.
Industry payments across VA — which companies pay providers there.
